BioNTech says ‘no evidence’ its jabs need adapting for variants

German firm BioNTech said Monday that the COVID-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.